'Vitamin D deficiency may increase multiple sclerosis risk'

Image
Press Trust of India Boston
Last Updated : Sep 14 2017 | 3:57 PM IST
Low levels of the 'sunshine vitamin' may increase the risk of developing multiple sclerosis in women, a study has found.
Multiple sclerosis (MS) disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems.
"There have only been a few small studies suggesting that levels of vitamin D in the blood can predict risk," said Kassandra Munger, from the Harvard TH Chan School of Public Health in the US.
"Our study, involving a large number of women, suggests that correcting vitamin D deficiency in young and middle-age women may reduce their future risk of MS," said Munger.
Researchers used a repository of blood samples from more than 800,000 women in Finland, taken as part of prenatal testing.
They identified 1,092 women who were diagnosed with MS an average of nine years after giving the blood samples. They were compared to 2,123 women who did not develop the disease.
Deficient levels of vitamin D were defined as fewer than 30 nanomoles per litre (nmol/L).
Insufficient levels were 30 to 49 nmol/L and adequate levels were 50 nmol/L or higher.
Of the women who developed MS, 58 per cent had deficient levels of vitamin D, compared to 52 per cent of the women who did not develop the disease.
Researchers found that with each 50 nmol/L increase in vitamin D levels in the blood, the risk of developing MS later in life decreased by 39 per cent.
In addition, women who had deficient levels of vitamin D had a 43 per cent higher risk of developing MS than women who had adequate levels as well as a 27 per cent higher risk than women with insufficient levels.
"More research is needed on the optimal dose of vitamin D for reducing risk of MS. But striving to achieve vitamin D sufficiency over the course of a person's life will likely have multiple health benefits," said Munger, lead author of the study published in the journal Neurology.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 14 2017 | 3:57 PM IST

Next Story